Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Pediatrics|March 14, 2022
Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab DosingStefanie W Benoit, Tsuyoshi Fukuda, Katherine VandenHeuvel, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 21, 2026
Inpatient Psychiatric Admission of a Durable Left Ventricular Assist Device Recipient: Multidisciplinary Care Plan and Policy FrameworkDeborah Fleck, Lucianne West, Molly Forsa, et al.
Bioorganic & Medicinal Chemistry Letters|July 14, 2009
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonistsDavid A Sandham, Claire Adcock, Kamlesh Bala, et al.
Nature Communications|February 10, 2023
Nanotopography reveals metabolites that maintain the immunomodulatory phenotype of mesenchymal stromal cellsEwan A Ross, Lesley-Anne Turner, Hannah Donnelly, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP<sub>2</sub> Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2007
2-Cycloalkyl phenoxyacetic acid CRTh2 receptor antagonistsDavid A Sandham, Clive Aldcroft, Urs Baettig, et al.
Bioorganic & Medicinal Chemistry|September 12, 2013
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseasesDavid A Sandham, Nicola Arnold, Heinrich Aschauer, et al.
Pageof 2